These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17318951)
1. Palliative radiotherapy in patients with multiple myeloma. Yaneva MP; Goranova-Marinova V; Goranov S J BUON; 2006; 11(1):43-8. PubMed ID: 17318951 [TBL] [Abstract][Full Text] [Related]
2. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Olivier KR; Schild SE; Morris CG; Brown PD; Markovic SN Cancer; 2007 Oct; 110(8):1791-5. PubMed ID: 17721993 [TBL] [Abstract][Full Text] [Related]
3. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Stölting T; Knauerhase H; Klautke G; Kundt G; Fietkau R Strahlenther Onkol; 2008 Sep; 184(9):465-72. PubMed ID: 19016025 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in the management of solitary extramedullary plasmacytoma. Chao MW; Gibbs P; Wirth A; Quong G; Guiney MJ; Liew KH Intern Med J; 2005 Apr; 35(4):211-5. PubMed ID: 15836498 [TBL] [Abstract][Full Text] [Related]
6. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy. Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053 [TBL] [Abstract][Full Text] [Related]
7. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases. Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S J BUON; 2009; 14(2):245-9. PubMed ID: 19650174 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Ozsahin M; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Dinçbas FO; Landmann C; Castelain B; Buijsen J; Curschmann J; Kadish SP; Kowalczyk A; Anacak Y; Hammer J; Nguyen TD; Studer G; Cooper R; Sengöz M; Scandolaro L; Zouhair A Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):210-7. PubMed ID: 16229966 [TBL] [Abstract][Full Text] [Related]
9. Elderly patients with painful bone metastases should be offered palliative radiotherapy. Campos S; Presutti R; Zhang L; Salvo N; Hird A; Tsao M; Barnes EA; Danjoux C; Sahgal A; Mitera G; Sinclair E; DeAngelis C; Nguyen J; Napolskikh J; Chow E Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1500-6. PubMed ID: 19540056 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL; Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101 [TBL] [Abstract][Full Text] [Related]
11. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978 [TBL] [Abstract][Full Text] [Related]
12. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count. Perosa F; Minoia C; Favoino E; Prete M; Dammacco F Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and staging systems of multiple myeloma: Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664 [TBL] [Abstract][Full Text] [Related]
14. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care. Wu JS; Kerba M; Wong RK; Mckimmon E; Eigl B; Hagen NA Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):533-8. PubMed ID: 19910133 [TBL] [Abstract][Full Text] [Related]
16. [Neurologic sequelae of bone changes in multiple myeloma and its therapy]. Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341 [TBL] [Abstract][Full Text] [Related]
17. Palliative radiation therapy of symptomatic recurrent bladder cancer. Yi SK; Yoder M; Zaner K; Hirsch AE Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350 [TBL] [Abstract][Full Text] [Related]
19. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M J BUON; 2009; 14(1):33-40. PubMed ID: 19373944 [TBL] [Abstract][Full Text] [Related]
20. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Kim MM; Rana V; Janjan NA; Das P; Phan AT; Delclos ME; Mansfield PF; Ajani JA; Crane CH; Krishnan S Acta Oncol; 2008; 47(3):421-7. PubMed ID: 17899453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]